Medical AI promises to democratize healthcare access through automated diagnostics and personalized treatment plans. However, current FDA frameworks struggle to keep pace with rapid model iterations. Practitioners must navigate a fragmented regulatory environment to ensure patient safety. This gap creates significant legal risks for clinics deploying unvetted tools in clinical settings.